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Abstract
Overexpression of multidrug transporters is a well-established mechanism of resistance to chemotherapy, but other
changes may be co-selected upon exposure to drugs that contribute to resistance. Using a model of J774 macrophages
made resistant to the fluoroquinolone antibiotic ciprofloxacin and comparing it with the wild-type parent cell line, we
performed a quantitative proteomic analysis using the stable isotope labeling with amino acids in cell culture technology
coupled with liquid chromatography electrospray ionization Fourier transform tandem mass spectrometry (LC-ESI-FT-MS/
MS) on 2 samples enriched in membrane proteins (fractions F1 and F2 collected from discontinuous sucrose gradient). Nine
hundred proteins were identified with at least 3 unique peptides in these 2 pooled fractions among which 61 (F1) and 69
(F2) showed a significantly modified abundance among the 2 cell lines. The multidrug resistance associated protein Abcc4,
known as the ciprofloxacin efflux transporter in these cells, was the most upregulated, together with Dnajc3, a protein
encoded by a gene located downstream of Abcc4. The other modulated proteins are involved in transport functions, cell
adhesion and cytoskeleton organization, immune response, signal transduction, and metabolism. This indicates that the
antibiotic ciprofloxacin is able to trigger a pleiotropic adaptative response in macrophages that includes the overexpression
of its efflux transporter.
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Introduction
The plasma membrane is a receptacle to key molecules vital for
the cellular integrity, and critical activities such as self-recognition,
environment sensing, and communication are mediated by
membrane proteins. Substance transport across membranes is
fundamental to the maintenance of cellular homeostasis and is
accomplished by ATP-binding cassette (ABC) transporters, one of
the most conserved family of proteins present in all cell types [1,2].
Under environmental changes, cells respond by altering their gene
expression to restore homeostasis and survive. This is well
illustrated in cells exposed to potentially toxic drugs in which
diverse cytoprotective mechanisms can be set off conferring to
them a resistant phenotype. A commonly observed biological
strategy is the reduction of the intracellular drug accumulation by
overexpression of multidrug efflux transporters of the ABC
superfamily [3]. Yet, drug-resistant cells may present other less
evident mechanisms operating synergistically. The fact that drug-
resistant cell lines present higher levels of resistance than their
transfected counterparts suggests indeed that other uncharacter-
ized functions might contribute to the resistance [3]. In this
respect, profiling of protein abundance may help to uncover the
extent of the impact of chronic exposure to a toxic drug.
Previous work from our laboratory has shown that the
fluoroquinolone antibiotic ciprofloxacin can select for a resistant
phenotype in J774 mouse macrophages that had been exposed
chronically to high concentrations of this drug [4]. This phenotype
is characterized by a reduced accumulation and an increased
efflux of the drug that we could attribute to an increase in the
expression of the multidrug transporter Mrp4 encoded by the
Abcc4 gene located on chromosome 14 [5]. Molecular cytogenetic
experiments showed that this overexpression is linked to Abcc4
gene overrepresentation, grading from a partial trisomy of
chromosome 14 at the first step of selection, to low-level
amplifications of Abcc4 locus, up to high-level amplification of
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Abcc4 as homogeneous staining region (hsr), inserted on 3 different
derivative chromosomes [6].
To examine whether exposure and resistance to the toxic effects
of ciprofloxacin could be associated with other, unanticipated
changes in the membrane proteome, we have now performed a
global quantitative analysis using stable isotope labeling with
amino acids in cell culture (SILAC) technology to compare the
proteins expressed in membranes isolated from ciprofloxacin-
resistant (CIP-R) J774 murine macrophages vs. their wild-type
(WT) counterparts. SILAC is a potent technique for direct
qualitative as well as quantitative comparison of proteomes [7].
It has been successfully used to evidence biological pathways
altered in cisplatin-resistant cells [8]. Here, we have focused our
analysis on enriched membrane fractions isolated from sucrose
gradient interfaces, which allowed us to confirm a large abundance
of Mrp4 in CIP-R cells. Yet, we also evidenced a modulation in
the expression of multiple surface and intracellular membrane
proteins with variety of functions. The data therefore suggest that
along with the acquisition of a targeted-resistant mechanism
(Mrp4 overexpression), cells surviving the chronic stress imposed
by high ciprofloxacin concentrations simultaneously modify
multiple pro-survival pathways to reach a new homeostatic
equilibrium. In a broader context, they demonstrate the interest
of the SILAC approach for unraveling pleiotropic changes
occurring in cells upon drug exposure.
Results and Discussion
Membrane Proteins Preparation
Figure 1 shows the isolation of samples enriched in plasma
membrane by the discontinuous sucrose gradient method. The
multipass plasma membrane transporter MRP1 was used as an
indicator for enrichment in cell surface proteins and MDCKII-
MRP1 cells overexpressing this protein were used to set up the
fractionation conditions and the optimized protocol was applied to
J774 macrophages. MRP1 levels were monitored by Western
blotting of the fractions isolated from 5 sucrose density-interphases
(F1 to F5). The mitochondrial marker prohibitin was used to
evaluate the purity of each fraction, given that this organelle is the
most common contaminant in this kind of preparations [9]. When
using MDCKII-MRP1 cells, protein samples collected from
interphases F1 to F3 showed increased MRP1 levels with a
concomitant rise in prohibitin. Samples from WT-J774 macro-
phages presented an enrichment of Mrp1 in the equivalent
fractions, with F1 and F2 displaying the lowest mitochondrial
contamination. Based on these results, membrane samples isolated
at the sucrose density-interphases F1 and F2 were selected for
comparative and quantitative proteomic analysis, using pooled F1
(F1WT+F1CIP-R) and F2 (F2WT+F2CIP-R) membrane samples as
depicted in Figure 2. A possible drawback in this experimental
design is that membranes samples for each WT and CIP-R cells,
had to be prepared and isolated independently (because of the
intensive labor and instrumental constraints), and mixed only prior
to the separation by SDS-PAGE. We can therefore not exclude
slight variations in the purification conditions.
Protein Identification by LC-MS/MS
After LC-MS analysis of the SDS-PAGE gel bands, a total of
122,542 and 111,580 MS/MS spectra were acquired from the
pooled membrane fractions F1 and F2, respectively. For each
pooled fraction, after protein database searching and automatic
validation using TPP’s PeptideProphet and ProteinProphet tools,
45,947 and 49,268 peptides were identified, accounting for 1061
and 1144 proteins in pooled membrane fractions F1 and F2,
respectively. At peptide level, PeptideProphet applied a 70%
confidence threshold for positive identifications. During the
further processing of the ProteinProphet results, EXCELH
exported protein lists of individual LC-MS experiments were
reorganized using in-house written VBA-scripts. Only protein hits
with probabilities higher than 0.95 were retained, and redundant
hits, appearing in multiple, often adjacent gel bands, were
grouped. No decoy proteins were identified with more than 2
unique peptide sequences. Therefore, a list of proteins with at least
3 unique peptides identified within an individual LC-experiment
was generated reflecting very significant and unambiguously
identified proteins (Table S1). A total of 651 and 735 proteins
were unambiguously identified in the pooled F1 sample and
pooled F2 sample, respectively, out of which 486 were present in
both fractions, leading to a total number of 900 unique mouse
proteins recognized. Additionally, 386 and 381 proteins repre-
sented by only 1 or 2 peptides were recovered in pooled fraction
F1 and F2 with a respectively false discovery rate of 3.5% and
4.5%, correlating well with the 0.95 significance threshold used by
ProteinProphet (Table S2).
To assess the contribution of proteins from plasma membrane
and other cellular organelles to the total protein hits, an analysis
according to the cellular compartment and biological function was
performed based on the protein’s Gene Ontology (GO) terms.
From all identified proteins, 17% were plasma membrane
proteins. Proteins from the endomembrane system accounted for
44% of the sample proteins (15% from ER/Golgi, 5% from
ribosomes, 7% from mitochondria, 8% from endosomes/lyso-
somes, and 9% from nucleus) whereas 17% were assigned as
unknown membrane proteins. Finally, 6% of the sample
corresponded to structural proteins of the cytoskeleton, 7% to
cytosolic and 4% to extracellular proteins (Figure 3, left). Based on
their biological function (Figure 3, right), most of these proteins are
involved in transmembrane or intracellular transport mechanisms
(27%) or metabolic processes (30%; among which 17% in the
metabolism of proteins; 5%, of nucleic acids; 4%, of carbohy-
drates; and 4%, of lipids).
Quantitative SILAC-based Analysis
Final protein abundance ratios were calculated by averaging the
logarithmic based 2 transformed L/H ratios of a particular protein
scattered in multiple, often adjacent, gel bands. After normaliza-
tion towards the median, the resulting histograms fit a Gaussian
distribution for both pooled membrane fractions (Figure 4).
Therefore, albeit that pooling of light (CIP-R) and heavy (WT)
labeled proteins was done after purification of the membrane
fractions, the mixture was composed of a 1:1 proportion,
validating the experimental method and parameters. In pooled
fraction F1, we detected 61 unambiguously identified proteins that
show a significant (P-value,0.05) difference in protein abundance
ratios between WT and CIP-R cells (Table 1). Similarly, pooled
fraction F2 data demonstrated 69 proteins with altered protein
abundance between both proteomes (Table 2). Several proteins
display a significant change in expression level in only one of these
two fractions. These differences are expected in our approach,
where pooled F1 and F2 fractions differ in their enrichment in
plasma membrane and constitute therefore partially different
proteomes.
When examining the function of the differentially expressed
proteins (Figure 4), we observed a small enrichment of proteins
involved in cell adhesion, motility and immune response (11%, vs.
5% of identified proteins) in comparison with the totality of
proteins identified. In contrast, proteins involved in structural
Ciprofloxacin-Resistant Macrophages and SILAC
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Figure 1. Plasma membrane enrichment strategy. Left: Illustration of the discontinuous sucrose gradient. Sucrose solutions densities (see
materials and methods) and the resulting interphases (F1 to F5) are depicted before (thin lines) and after centrifugation (irregular lines). Right:
Expression of a plasma membrane protein MRP1 and prohibitin, a mitochondrial marker in sucrose interphases. MRP1 and prohibitin were detected
by Western blot in each of the interphases of MDCKII-MRP1 cells (top) and wild-type J774 macrophages (bottom). Anti-MRP1 (1:2000) and anti-
prohibitin (1:1000) antibodies were followed by the appropriate anti-IgG HRP-labeled antibodies.
doi:10.1371/journal.pone.0058285.g001
Figure 2. Overview of the SILAC experimental approach. Left: WT-J774 and CIP-R cells were cultured in media containing 13C6-Lys/
13C6-Arg
and 12C6-Lys/
12C6-Arg, respectively. Following isolation of membrane samples for each strain independently, equal amounts from each matching
fraction were pooled (F1wt+F1CIP and F2wt+F2CIP) and then separated by SDS-PAGE. Right: Lanes of pooled sample fractions were first cut in sections
(A-K for pooled F1 and A-J for pooled F2) and further sliced in thinner, numbered gel plugs which were processed for Trypsine in-gel digestion as
described in the experimental procedures. For pooled F1 gel line, section A includes gel plugs from 1 to 8, B 9 to 14, C 15 to 20, C 21 to 24, E 25 to 29,
F 33 to 35, G 36 to 41, H 42 to 45, I 46 to 52, J 53 to 60 and K 61 to 65. For sample pooled F2 gel line, section A includes bands 1 to 6, B 7 to 11, C 12 to
18, D 19 to 25, E 26 to 32, F 33 to 39, G 40 to 47, H 48 to 56, I 57 to 65 and J 66 to 72.
doi:10.1371/journal.pone.0058285.g002
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functions were modulated in lesser extent (3%, vs. 7% of identified
proteins associated with cytoskeleton).
Proteins Modulated Upon Chronic Exposure to
Ciprofloxacin
Overexpression of the multidrug transporter Abcc4
involved in ciprofloxacin efflux. In both membrane fractions,
the multidrug transporter Abcc4/Mrp4 (Q3TZN9) belonging to
the ABC superfamily [10] was the most abundant protein in CIP-
R cells (see Figure 5 for an example of a MS/MS spectrum which
contributed to the identification of Mrp4). This observation is
coherent with our previous observation that Mrp4 is the main
ciprofloxacin transporter in these cells and is markedly overex-
pressed at both the protein and mRNA levels in CIP-R cells [5].
As we were interested in multidrug resistance, we also looked for
other ABC multidrug transporters. Only Abcb1b (Mdr1) (one of
the two murine P-gp isoforms), and Abcc1 were detected, but
without any difference of expression between the two cell lines (See
Tables S1 and S2). Abcc2 (Mrp2), for which we have already
demonstrated an overexpression in resistant cells, was not detected
here, probably due to its low abundance [5]. Mrp4 has a natural
function in the export of cyclic nucleotides like cAMP and
proinflammatory mediator leukotriene [11,12]. Massive produc-
tion of Mrp4 may therefore have an impact on intra- en
extracellular signaling as will be demonstrated below.
Overexpression of p58IPK/Dnajc3 and evaluation of
resistance to ER stress. In both membrane fractions,
P58IPK/Dnajc3 (Q91YW3) is also strongly more abundant in
CIP-R macrophages. This was confirmed by Western-Blot
(Figure 6). The corresponding gene is found 250 kB downstream
of the Abcc4 gene, located on mouse chromosome 14E4, suggesting
that overproduction of the corresponding proteins is due to gene
amplification of a chromosomal fragment. This hypothesis has
been recently confirmed by FISH experiments demonstrating a
co-amplication of these two genes [6]. P58IPK/Dnajc3 is a
member of the DnaJ/Hsp40 (heat shock protein 40) co-
chaperones family [13] and is considered to be an ER stress
inducible chaperone and attenuator of the unfolding protein
response (UPR [14,15]). The massive expression of Mrp4 at the
plasma membrane might generate a burden to the ER where
membrane protein folding and maturation takes place. We
therefore compared the response to ER stress in the two cell lines
by measuring the expression of the ER chaperone Bip/Grp78 also
known as Hspa5 heat shock protein 5 [16] in control conditions or
after 24 h exposure to 0.2 mM ciprofloxacin or 0.5 mg/ml of
tunicamycin, an UPR-stress inducer. Our SILAC analysis did not
reveal any change in the expression of this protein (see Table S1)
in standard conditions of culture (i.e. control medium for WT cells
and medium added by 0.2 mM of ciprofloxacin for CIP-R cells),
which was further confirmed by immunoblotting of whole cell
lysates (Figure 6) or of membrane protein samples (not shown)
from both cell lines. Yet, both ciprofloxacin and tunicamycin
triggered a sustained over-expression of Grp78 in WT cells, but
only tunicamycin in CIP-R cells (Figure 7). The absence of effect
of ciprofloxacin in CIP-R cells could easily be attributed to the
reduced cellular accumulation of the drug resulting from the
overexpression of its efflux transporter [4]. Yet, the absence of
protection against tunicamycin-induced stress in CIP-R cells
rather suggests that the overexpression of the two proteins,
Mrp4 and Dnajc3, is coincidental and related to their close
location on the chromosome [6]. Most likely, P58IPK/Dnajc3 does
not play a particular role in the resistant phenotype. This needs
however to be further explored by examining other proteins
involved in the ER stress cascade.
Moreover, P58IPK/DNAJC3 protects cells against apoptosis by
preventing the activation of NF-kB signal cascades [17]. Of
interest, ciprofloxacin has been shown capable of causing cell
death by apoptosis in specific models (see [18] for a recent
example). Intriguingly, however, some proteins that are under the
transcriptional control of NF-kB are found more abundant in CIP-
R cells, like MHC2-class I antigens [P01899, P01900, P01901,
P01902] [19], neuronal cell adhesion molecule [Q810U4] [20],
cathepsin L1 [P06797] [21], insulin-like growth factor1 receptor
[Q60751] [22], CD40 [P27512], CD86 [P42082] [23], and
osteopontin precursor [P10923] [24] but the NF-kB repressor
Myb-binding protein 1A [Q7TPV4] [25] was down regulated.
Modulation of lipid synthesis. One of the physiological
functions attributed to Mrp4 is the transport of lipid mediators like
leukotrienes and prostaglandins [11,26]. In this context, our
analysis also highlights changes in the expression of proteins
involved in lipid metabolism, which could have significant impact
in the composition of the membranes and important consequences
for intracellular transduction activities. In particular, the lipid
phosphate phosphatase 1 (LPP-1or PAP-2a [Q61469]) and the
Figure 3. Classification of the identified proteins. Distribution charts of cellular localization (left) and biological function (right) of all proteins
identified with high significance in both pooled F1 and F2 fractions. Proteins with multiple cellular localizations or biological functions are assigned to
the one it is best known. Transporter proteins are involved in both transmembrane and intracellular transport.
doi:10.1371/journal.pone.0058285.g003
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inositol monophosphatase 3 [Q80V26] [27,28], 2 proteins
participating in the regulation of the activity of bioactive lipids
and mediators of the intracellular phosphoinositide-based signal-
ing [29], were upregulated. The low-density receptor protein
LDRL [P35951] was upregulated as well [30]. On the contrary,
two lysosomal hydrolases acting on lipids, namely glucosylcer-
amidase [P17439] [31] and acid ceramidase [Q9WV54] [32] as
well as the glycosyltransferase beta-1,4 N-acetylgalactosaminyl-
transferase 1 (GalNAc-T; Q09200) involved in the biosynthesis of
gangliosides GM2, GD2 and GA2 [33] were downregulated in
CIP-R cells. Some of these changes could be attributed to reduced
cAMP levels, as for example for acid ceramidase [34].
Modulation of intracellular protein transport and
recycling. Driving increased amounts of Mrp4 at the cell
surface may require modulation of the intracellular pathways of
protein transport and/or recycling. Although not optimized to
detect proteins associated to intracellular membranes, our
proteomic analysis detected changes in the expression of proteins
implicated in intracellular trafficking and recycling in CIP-R
macrophages. We found RAB11 family interacting protein 1 class
1 (Rab11-FIP1; Q9D620) positively modulated. This protein had
been proposed to regulate Rab11 localization and to recruit
additional factors to different endocytic compartments [35]. In
contrast, the Rab4-interacting protein (RabIP4; Q8BIJ7), a
protein that in conjunction with Rab4 seems to be involved in
early endosomal traffic [36] was found down regulated in CIP-R
cells. Apparently, RabIP4 could provide directionality to a
backward traffic from the recycling endosomes to sorting
endosomes [37]. The upregulated serine/threonine kinase lemur
tyrosine kinase 2 (LMTK2; Q3TYD6) is involved in the transition
Figure 4. Sample quantization and classification of modulated proteins. Top: Histograms showing distribution of log2 protein Light/Heavy
ratios after normalization toward the median for proteins identified by 3 or more tryptic peptides from pooled F1 and F2 samples, respectively. After
normalization the distributions fitted to a Gaussian curve indicating that protein ratios have a median of 0 on the log2 scale as expected for a 1:1
mixture. Bottom: Distribution chart of the biological function of proteins that show a 95% significant differential abundance ratio in pooled fraction
F1 or F2.
doi:10.1371/journal.pone.0058285.g004
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Table 1. Proteins with change in expression levels in pooled fractions F1.
# Accession Protein name Log2L/H P-value Coverage F2
Over-expressed proteins
1 Q3TZN9 ABCC4/MRP4 efflux transporter + a 0.000 34.9 + (0.00)
2 Q91YW3 DnaJ homolog subfamily C member 3 (p58IPK) 4.48 0.000 20.2 3.83(0.00)
3 Q3TYT8 Collectin-12 3.34 0.000 6.1 20.38(0.34)
4 P01899 H-2 class I histocompatibility antigen, D-B alpha chain precursor 3.06 0.000 12.4 2.32(0.00)
5 Q3U651 Cathepsin D 2.44 0.000 5.1 ni.
6 P01900 H-2 class I histocompatibility antigen. D-D alpha chain precursor 2.16 0.000 37.5 1.80(0.00)
7 Q91VK4 Integral membrane protein 2C (CT-BRI3) 2.00 0.000 20.4 0.73(0.24)*
8 P28798 Granulins precursor (proepithelin) 1.99 0.000 13.9 ni.
9 Q810U4 Neuronal cell adhesion molecule precursor (NrCam) 1.95 0.000 13.6 2.28(0.00)
10 P10404 MLV-related proviral Env polyprotein precursor 1.90 0.000 6.2 20.14(0.72)
11 Q61207 Sulfated glycoprotein 1 precursor (prosaposin) 1.81 0.001 11.3 1.33(0.00)
12 P12023 Amyloid beta A4 protein precursor (APP) 1.75 0.001 12.3 1.41(0.02)*
13 P97333 Neuropilin-1 precursor (CD304) 1.64 0.002 22.0 1.38(0.00)
14 O09126 Semaphorin-4D precursor (CD100) 1.63 0.002 8.7 ni.
15 Q80V26 Inositol monophosphatase 3 1.58 0.003 6.2 1.77(0.00)*
16 P06797 Cathepsin L1 precursor 1.56 0.004 34.4 0.44(0.31)*
17 Q61469 Lipid phosphate phosphohydrolase 1 (PAP-2a) 1.53 0.004 5.7 ni.
18 Q8K482 EMILIN-2 precursor 1.48 0.006 8.3 0.42(0.33)
19 P03975 IgE-binding protein (IAP) 1.48 0.006 19.4 1.99(0.00)
20 Q9D620 Rab11 family-interacting protein 1 (Rab-coupling protein) 1.33 0.013 7.6 1.31(0.00)
21 P42082 T-lymphocyte activation antigen CD86 1.32 0.014 20.4 0.87(0.04)
22 Q60751 Insulin-like growth factor 1 receptor precursor (CD221) 1.29 0.016 8.3 ni.
23 Q05910 ADAM 8 precursor (CD156a) 1.28 0.017 11.6 1.92(0.00)
24 Q8BWW9 Serine/threonine-protein kinase N2 1.27 0.017 14.3 ni.
25 P01902 H-2 class I histocompatibility antigen, K-D alpha chain precursor 1.25 0.019 29.3 0.99(0.02)
26 P27512 Tumor necrosis factor receptor superfamily member 5 precursor (CD40) 1.21 0.023 12.8 0.73(0.24)*
27 P10923 Osteopontin precursor 1.21 0.024 15.0 20.66(0.10)
28 P16675 Lysosomal protective protein precursor (Cathepsin A) 1.20 0.025 14.1 ni.
29 A2AR26 Solute carrier family 2, member 6 (Slc2a6) 1.18 0.027 7.9 2.09(0.00)
30 O89103 Complement component C1q receptor precursor 1.18 0.028 30.0 0.57(0.19)
31 O89017 Legumain precursor 1.16 0.030 17.7 0.47(0.45)*
32 O35474 EGF-like repeat and discoidin I-like domain-containing protein 3 precursor 1.14 0.033 9.6 20.90(0.02)
33 P35951 Low-density lipoprotein receptor precursor 1.12 0.036 12.0 0.82(0.06)
Lower-expressed proteins
1 P58681 Toll-like receptor 7 precursor 24.41 0.000 11.0 23.89(0.00)
2 P47738 Aldehyde dehydrogenase, mitochondrial precursor 22.74 0.000 24.1 21.41(0.00)
3 P53026 60S ribosomal protein L10a 22.61 0.000 18.9 0.13(0.76)
4 A1L314 Macrophage expressed gene 1 protein (Mpeg1) 22.14 0.000 18.0 21.77(0.00)
5 Q03265 ATP synthase subunit alpha, mitochondrial precursor 22.07 0.000 28.2 20.92(0.02)
6 Q61549 Cell surface glycoprotein F4/80 21.78 0.001 6.8 ni.
7 P24063 Integrin alpha-L precursor (CD11a) 21.72 0.002 21.8 22.37(0.00)
8 Q3TVQ0 Formyltetrahydrofolate synthetase domain containing 1 21.61 0.003 4.1 20.77(0.06)
9 Q7TPV4 Myb-binding protein 1A 21.54 0.004 11.0 ni.
10 Q8CGK3 Lon protease homolog, mitochondrial precursor 21.54 0.004 4.0 ni.
11 P26443 Glutamate dehydrogenase 1, mitochondrial precursor 21.42 0.009 9.5 20.53(0.18)
12 Q3TFD0 Serine hydroxymethyltransferase 21.42 0.009 22.8 20.53(0.18)
13 P51675 C-C chemokine receptor type 1 (CD191) 21.42 0.009 8.2 ni.
14 P63038 60 kDa heat shock protein, mitochondrial precursor 21.37 0.012 36.8 20.50(0.21)
Ciprofloxacin-Resistant Macrophages and SILAC
PLOS ONE | www.plosone.org 6 March 2013 | Volume 8 | Issue 3 | e58285
of membrane vesicles from early endosomes to recycling
endosomes and interacts with the actin-based retrograde motor
protein myosin VI [38] involved in the movement of those vesicles
[39]. Two Dnajc13 homologues, different from p58IPK (RME-8
[Q8BNL1] and Q3UQJ), involved in endosomal trafficking [40],
were less expressed in CIP-R cells. In cells knock-out for RME-8,
the level of cargos, such as the epidermal growth factor receptor
(EGFR), is decreased while receptors that primarily recycle to the
plasma membrane remain unaffected [41]. Two other proteins
with a role in membrane trafficking were also modulated in the
resistant cells, namely copine [Q8C166] [42,43] and myoferlin
[Q69ZN7] [44]. The link between these changes and functionality
of Mrp4 at the cell membrane remains however to be established.
Modulation of adhesion and motility. Several integrins or
associated proteins were found modified in our proteomic
experiment. Thus, intregrin aL [P24063] was upregulated in
CIP-R cells, while a9 [Q3UT74] and the leukocyte surface
antigen CD47 [Q61735] (45) were downregulated. In addition,
various adhesion molecules implicated in tumorigenesis were
found up-regulated in ciprofloxacin-resistant macrophages. These
include neuropilin-1 [P97333], which is implicated in cell
proliferation, survival, and migration and protects cancer cells
from apoptosis [46], the cell adhesion molecule NrCAM
[Q810U4] that promotes cell growth and motility [47,48], the
extracellular matrix component and tumor progression marker
osteopontin [P10923] [49], and the metalloproteinase-disintegrin
ADAM8 [Q05910] [50].
Alteration of lysosomal proteome. Although the samples
were selected to be enriched in pericellular membrane proteins, we
also detected proteins associated to organelle membranes. In
particular, we found modifications in the expression of a series of
lysosomal proteins. Besides the lysosomal hydrolases acting on
lipids mentioned above, many other proteins were found
overexpressed in CIP-R cells, mainly: (i) precursor peptides of
cathepsin A [P16675], D [Q3U651] and L1 [P06797] that
intervene not only in proteolysis but also in inflammatory
processes and apoptosis [51] (ii) legumain [O89017], a member
of the C13 family of cysteine proteases, also found highly
upregulated in many murine and human tumors [52] and (iii)
prosaposin [Q61207], the precursor of lysosomal saposins A, B, C
and D that has been associated with cancer [53,54] and is
described as having growth, migration, and invasion promoting
activities and also anti-apoptotic effects [55–57]. It is established
that lysosomal enzymes are first translated as proenzymes that
become proteolytically activated within the lysosomes. Our GeLC
approach therefore is able to separately identify and quantify the
proteins processing states. Focusing on cathepsin B (P10605) for
example, our data indicate a significant up-regulation of the
cathepsin B precursor (MW 37.3 kDa), whereas the processed
enzyme (MW 27.5 kDa) shows no regulation between WT and
ciprofloxacin resistant cells (Figure S1 and Table S3). Averaging
the ratios for the different peptides, however, results in a clear but
not significant up-regulation of cathepsin B. Similar results are
obtained for cathepsins L1 and D. In addition, six out of the eight
(A to H) peripheral V1 subunits of the V-type ATPase [58] were
significantly downregulated in CIP-R. Of interest, we noted
previously that the basal level of ATP was increased in CIP-R cells
[4], possibly to insure the increased need in energy needed for
Mrp4 activity.
Alteration of cell signaling. A series of receptors playing a
role in macrophage differentiation or activation were expressed to
higher levels in CIP-R cells. This is the case for (i) the cytokine
receptor common subunit b (CSF2RB, CD131) which is a shared
component of Type I cytokine receptors (IL 3, IL 5 and GM-CSF)
[59], (ii) the a and b chains of tumor necrosis factor receptor
(CD40; P27512), a member of the tumor necrosis factor receptor
(TNF) receptor family, (iii) the insulin-like growth factor 1 receptor
(IGR-1 [Q60751] [60], a survival factor of malignant cells [61],
and (iv) single Ig IL-1 related receptor (Sigirr) or TIR8 [Q9JLZ8],
Table 1. Cont.
# Accession Protein name Log2L/H P-value Coverage F2
15 Q99KI0 Aconitate hydratase, mitochondrial precursor 21.37 0.012 11.2 20.38(0.34)
16 P38647 Stress-70 protein, mitochondrial precursor 21.37 0.012 8.0 20.10(0.79)
17 Q6P5F7 Protein tweety homolog 3 21.37 0.012 4.8 ni.
18 Q8CGC6 RNA-binding protein 28 21.26 0.020 4.0 ni.
19 Q91VE6 MKI67 FHA domain-interacting nucleolar phosphoprotein 21.16 0.033 13.2 20.05(0.90)
20 P20152 Vimentin 21.13 0.038 67.4 21.94(0.00)
21 Q69ZN7 Myoferlin 21,12 0.039 54.2 21.76(0.00)
22 P21956 Lactadherin precursor 21,11 0.040 21.8 20.57(0.15)
23 P57746 Vacuolar ATP synthase subunit D 21,11 0.040 18.6 21.49(0.00)
24 Q60932 Voltage-dependent anion-selective channel protein 1 21,09 0.045 39.9 20.69(0.15)*
25 Q3TJG0 Band 4.1-like protein 5 21,07 0.049 8.1 ni.
26 P50516 Vacuolar ATP synthase catalytic subunit A 21,07 0.049 42.5 21.92(0.00)
27 Q9DBG7 Signal recognition particle receptor subunit alpha (SRPa) 21,07 0.049 8.5 ni.
28 Q8JZR0 Long-chain-fatty-acid–CoA ligase 5 21,07 0.049 4.1 20.38(0.33)
List of the 61 differentially expressed proteins identified in pooled fractions F1, using a 0.95 significance threshold (P-value). Accession corresponds to the Uniprot
accession number. Log2L/H gives the logarithm of the average ratio of light (CIP-R) labeled peptides over heavy (WT) labeled peptides to the base 2:+indicates that no
heavy labeled peptides could be detected. Coverage is the sequence coverage percentile of identified peptides in each protein. F2 shows Log2L/H ratio and P-value of
the protein in pooled fractions F2: values in italic do not meet the 0.95 significance threshold,
*protein identification and quantification is only based on 1 or 2 tryptic peptides, ni., not identified.
asignal in the WT cells not above the noise level.
doi:10.1371/journal.pone.0058285.t001
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Table 2. Proteins with change in expression levels in pooled fractions F2.
# Accession Protein name Log2L/H P-value Coverage F1
Over-expressed proteins
1 Q3TZN9 ABCC4/MRP4 efflux transporter +a 0.000 26.9 +(0.00)
2 Q91YW3 DnaJ homolog subfamily C member 3 (p58IPK) 3.83 0.000 20.0 4.48(0.00)
3 P01899 H-2 class I histocompatibility antigen, D-B alpha chain precursor 2.32 0.000 12.4 3.06(0.00)
4 Q810U4 Neuronal cell adhesion molecule precursor (NrCam) 2.28 0.000 7.1 1.95(0.00)
5 A2AR26 Solute carrier family 2, member 6 (Slc2a6) 2.09 0.000 11.7 1.18(0.03)
6 P63085 Mitogen-activated protein kinase 1 (p42-MAPK) 2.09 0.000 30.2 20.04(0.94)
7 Q61213 Gag 2.02 0.000 4.6 1.84(0.03)*
8 P03975 IgE-binding protein (IAP) 1.99 0.000 36.6 1.48(0.01
9 P01900 H-2 class I histocompatibility antigen, D-D alpha chain precursor 1.80 0.000 23.3 2.16(0.00)
10 Q3UT74 Integrin alpha 9 protein (Itga9) 1.67 0.000 8.4 1.78(0.03)*
11 P26955 Cytokine receptor common subunit beta (CD131) 1.48 0.001 8.4 2.47(0.00)*
12 P97333 Neuropilin-1 precursor 1.38 0.001 15.0 1.64(0.00)
13 Q921H8 3-ketoacyl-CoA thiolase A, peroxisomal precursor 1.38 0.001 16.0 0.75(0.16)
14 Q61207 Sulfated glycoprotein 1 precursor (prosaposin) 1.33 0.002 7.5 1.81(0.00)
15 Q8C166 Copine-1 1.32 0.002 6.3 0.62(0.25)
16 Q9JLZ8 Single Ig IL-1-related receptor 1.31 0.002 7.8 1.16(0.17)*
17 Q9D620 Rab11 family-interacting protein 1 (Rab-Coupling protein) 1.31 0.002 24.5 1.33(0.01)
18 Q05910 ADAM 8 precursor (CD156a) 1.29 0.003 7.7 1.28(0.02)
19 Q99LS5 Tex264 protein 1.28 0.003 4.5 ni.
20 P12265 Beta-glucuronidase precursor 1.22 0.005 21.0 0.78(0.14)
21 Q3TYD6 Serine/threonine-protein kinase LMTK2 1.13 0.009 8.2 0.88(0.29)*
22 O54782 Epididymis-specific alpha-mannosidase precursor 1.08 0.012 7.1 0.90(0.09)
23 Q9DC29 Mitochondrial ATP-binding cassette sub-family B member 6 1.06 0.013 14.8 1.04(0.05)
24 Q9D1R9 60S ribosomal protein L34 1.05 0.015 23.1 ni.
25 P01902 H-2 class I histocompatibility antigen, K-D alpha chain precursor 0.99 0.021 26.4 1.25(0.02)
26 P12970 60S ribosomal protein L7a 0.98 0.023 33.1 20.82(0.13)
27 Q09200 Beta-1,4 N-acetylgalactosaminyltransferase 1 0.98 0.023 20.1 0.86(0.11)
28 Q924S8 Sprouty-related, EVH1 domain-containing protein 1 0.97 0.024 11.3 1.15(0.08)*
29 P31996 Macrosialin precursor (CD68) 0.97 0.025 5.5 0.50(0.35)
30 P35979 60S ribosomal protein L12 0.92 0.033 15.2 ni.
31 Q61033 Lamina-associated polypeptide 2 (Lap2) 0.88 0.041 4.2 ni.
32 P42082 T-lymphocyte activation antigen CD86 0.87 0.044 22.3 1.32(0.01)
33 Q61735 Leukocyte surface antigen CD47 0.87 0.044 8.9 0.92(0.08)
34 P62270 40S ribosomal protein S18 0.85 0.048 17.1 ni.
Lower-expressed proteins
1 P58681 Toll-like receptor 7 precursor 23.89 0.000 15.0 24.41(0.00)
2 P24063 Integrin alpha-L precursor (CD11a) 22.37 0.000 8.1 21.72(0.00)
3 Q3UQJ7 DnaJc 13 homolog, N-terminal fragment RME-8 22.24 0.000 13.1 ni.
4 Q8BNL1 DnaJc 13 homolog, C-terminal fragment RME-8 22.07 0.000 6.0 ni.
5 P62814 Vacuolar ATP synthase subunit B, brain isoform 22.00 0.000 35.4 20.85(0.12)
6 Q8BVE3 Vacuolar ATP synthase subunit H 21.98 0.000 25.3 20.67(0.21)
7 P20152 Vimentin 21.94 0.000 30.0 21.13(0.04)
8 P50516 Vacuolar ATP synthase catalytic subunit A 21.92 0.000 48.8 21.07(0.05)
9 P50518 Vacuolar ATP synthase subunit E 1 21.91 0.000 34.5 20.90(0.20)
10 Q9Z1G3 Vacuolar ATP synthase subunit C 1 21.90 0.000 24.1 20.69(0.20)
11 A1L314 Macrophage expressed protein (Mpeg1) 21.77 0.000 8.4 22.14(0.00)
12 Q69ZN7 Myoferlin 21.76 0.000 32.6 21.12(0.04)
13 P57746 Vacuolar ATP synthase pump subunit D 21.49 0.000 29.6 21.11(0.04)
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which regulates cancer-related inflammation and autoimmunity
[62].
On the contrary, the Toll-like receptor 7 (TLR 7; P58681) was
the lower expressed protein in resistant cells, in both analyzed
fractions (see also Figure 6 for validation by western-blot). This
could be consecutive to the dowregulation of Sigirr, a negative
regulator of the IL-1 receptor/TLR system [62]. In the context of
this study, an interesting characteristic of this protein is that it
recognizes nucleosides and nucleotides [63] as does Mrp4.
Among proteins involved in differentiation, we found an
increased expression of the histocompatibility H-2 class I antigen
chain precursors (P01902). Interestingly, a proteomics study
reports on the induction of major histocompatibility complex
(MHC) class I molecules in activated macrophages [64]. On the
contrary, we evidenced a reduction in the expression of a F4/F80
receptor [Q61549], a specific macrophage cell-surface marker for
murine macrophages [65] and of the precursor of the macrophage
scavenger receptors (MSR) I and II [P30204, which are expressed
during differentiation of monocytes into macrophages [66].
Modulation of other cell surface proteins. Among other
surface proteins, we also detected in CIP-R cells a down-regulation
of Mpeg-1 [A1L314], a macrophage porin-like protein [67], and
an up-regulation of semaphorin-4D (CD100 [O09126]) [68], of
collectin-12 [Q3TYT8], a scavenger receptor [69], and of the C–
C chemokine receptor type 1 CD191 [P51675] [70]. Peculiar
outcomes were the overexpression of the amyloid beta (A4)
precursor protein (App [P12023]; validated by Western-Blot, see
Figure 6), the MLV related proviral Env polyprotein precursor
[P10404], and the IgE binding protein or intracisternal A-Particle
(IAP [P03975]). The IAP are encoded by retrovirus-like mobile
elements present in the mouse genome [71] where they can
transpose and act as mutagenic agents [72]. For instance, it has
been shown that P-gp overexpression in a murine leukemic tumor
cell line (gene Abcb1a) is caused by gene amplification and also
transcriptional activation due to the insertion of a IAP in the
promoter region of the gene [73]. Whether this is also the
mechanism having led to gene amplification in our model needs to
be determined experimentally. We also detected in CIP-R cells an
increased amount of p42-MAPK [P63085], a serine/threonine
kinase that controls a wide range of cellular activities [74]. Yet,
peptides were located in bands corresponding to a much higher
molecular weight than that expected for the denatured p42-
MAPK polypeptide (band 6, .150 kDa).
Conclusion
This study is, to the best of our knowledge, the first one to
perform a SILAC analysis on purified membrane fractions of
eukaryotic cells, constituting a potentially useful technological
advance that may have several applications in biology or
pharmacology.
Table 2. Cont.
# Accession Protein name Log2L/H P-value Coverage F1
14 P47738 Aldehyde dehydrogenase, mitochondrial precursor 21.41 0.000 37.0 22.74(0.00)
15 O89001 Carboxypeptidase D precursor 21.34 0.001 5.3 20.67(0.21)
16 Q3U829 Uncharacterized protein 21.29 0.001 2.5 ni.
17 Q8R4Y4 Stabilin-1 precursor 21.12 0.005 1.8 ni.
18 P70290 55 kDa erythrocyte membrane protein (p55) 21.12 0.005 10.1 21.02(0.06)
19 Q80VQ0 Aldehyde dehydrogenase 3B1 21.11 0.005 22.6 20.92(0.09)
20 Q7TPR4 Alpha-actinin-1 21.06 0.008 26.9 20.72(0.21)*
21 P17439 Glucosylceramidase precursor 21.05 0.008 15.1 0.19(0.73)
22 Q9CPN8 Insulin-like growth factor 2 mRNA-binding protein 3 20.96 0.015 26.4 20.53(0.37)*
23 Q99K70 Ras-related GTP-binding protein C 20.93 0.019 8.8 20.99(0.09)*
24 P30204 Macrophage scavenger receptor types I and II (CD204) 20.92 0.020 32.1 20.23(0.67)
25 Q03265 ATP synthase subunit alpha, mitochondrial precursor 20.92 0.020 32.7 22.07(0.00)
26 P60122 RuvB-like 1 20.92 0.020 9.0 ni.
27 O35474 EGF-like repeat and discoidin I-like domain-containing protein 3 precursor 20.90 0.023 5.8 1.14(0.03)
28 Q91WB7 Ubiquitin domain-containing protein 1 20.90 0.023 10.6 20.59(0.32)*
29 P55302 Alpha-2-macroglobulin receptor-associated protein precursor 20.87 0.028 9.7 ni.
30 Q91VR2 ATP synthase subunit gamma, mitochondrial precursor 20.84 0.034 8.4 ni.
31 Q8BFR5 Elongation factor Tu, mitochondrial precursor 20.82 0.038 5.8 ni.
32 Q8BIJ7 RUN and FYVE domain-containing protein 1 (Rabip4) 20.82 0.040 13.3 20.44(0.46)*
33 Q3UH76 plexin B2 20.80 0.043 17.8 20.44(0.42)
34 O08599 Syntaxin-binding protein 1 20.80 0.043 9.9 20.11(0.83)
35 Q9WV54 Acid ceramidase precursor 20.79 0.046 18.3 20.10(0.85)
List of the 69 differentially expressed proteins identified in pooled fractions F2, using a 0.95 significancy threshold (P-value). Accession corresponds to the Uniprot
accession number. Log2L/H gives the logarithm of the average ratio of light (CIP-R) labeled peptides over heavy (WT) labeled peptides to the base 2:+indicates that no
heavy labeled peptides could be detected. Coverage is the sequence coverage percentile of identified peptides in each protein. F1 shows Log2L/H ratio and P-value of
the protein in pooled fractions F1: values in italic do not meet the 0.95 significance threshold,
*protein identification and quantification is only based on 1 or 2 tryptic peptides, ni., not identified.
asignal in the WT cells not above the noise level.
doi:10.1371/journal.pone.0058285.t002
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Thus, the analysis performed here clearly shows that exposure
of J774 macrophages to high concentrations of ciprofloxacin to
obtain cells that resist to drug concentrations that would kill parent
cells, induces pleiotropic alterations in protein expression. This
observation is in the line of recent proteomic studies of drug-
resistant cell lines that all highlight impressive modifications in the
profile of protein expression, most often related to a diversity of
metabolic pathways [8,75–77]. In the present case, the most
obvious change to explain the resistance phenotype is the
overexpression of the ciprofloxacin efflux transporter, a mecha-
nism observed for many other cytotoxic drugs. Quite intriguingly,
however, co-amplification of P58IPK/Dnajc3 does not seem to
contribute to resistance. Many of the other differentially expressed
cell surface receptors and cell surface signaling elements evidenced
in CIP-R macrophages are suggestive of activated macrophages,
or contribute to cell motility, adhesion, cytoskeleton, immune
response, activation of proinflammatory cytokines, angiogenesis,
differentiation, lipid metabolism, and cell proliferation. Thus,
virtually all of the regulated surface proteins in CIP-R cells have
been linked to malignancies and/or in a broader context,
conditions promoting cell growth and motility. It remains
nevertheless to be determined whether these changes are
contributing to resistance or are simply secondary to alterations
in regulatory pathways, for example as a consequence of altered
cAMP homeostasis. This would represent a piece of work by itself
for each group of modified proteins associated with a specific
biological function. Yet, confirming the significance of our results,
transcriptomic studies (including microarray analysis) of human
lymphocytes exposed to supratherapeutic concentrations of
ciprofloxacin similar to those used here, also revealed modulations
in mRNA of proteins belonging to major gene programs (like
signal transduction factors, cytokines, adhesion and apoptosis
related molecules), which share many commonalities with our own
data [78,79].
In a broader context, the fact that many of the proteins altered
in their expression upon exposure to ciprofloxacin were similar to
Figure 5. MS/MS spectrum of one of the Mrp4 peptides. The MS/MS spectrum is showing a CID fragmentation profile which was measured in
the LTQ ion trap mass analyzer. The double charged precursor ion (m/z 914.4136) was previously detected by the high-resolution FT-ICR mass
analyzer. Matched y- and b-ions are indicated above and below the amino acid sequence given in the one letter code.
doi:10.1371/journal.pone.0058285.g005
Ciprofloxacin-Resistant Macrophages and SILAC
PLOS ONE | www.plosone.org 10 March 2013 | Volume 8 | Issue 3 | e58285
those modified with other cytotoxic agents (including chemother-
apeutic agents), indicates that they are part of a global adaptative
response to xenobiotics.
Materials and Methods
Chemicals
Ciprofloxacin (98% purity) was kindly provided as standard for
microbiological evaluation by Bayer HealthCare A.G., Leverku-
sen, Germany. Camptothecin, tunicamycin and the zwitterionic
detergents ASB14 (3-[N,N-Dimethyl(3-myristoylaminopropyl) am-
monio]propanesulfonate Amidosulfobetaine-14) and C7BzO (3-(4-
Heptyl)phenyl-3-hydroxypropyl)dimethylammoniopropanesulfo-
nate) were obtained from Sigma-Aldrich (St. Louis, MO).
Cell Culture
J774 mouse macrophages (referred to as WT cells) were grown
in RPMI-1640 medium (Invitrogen, Carlsbad, CA) supplemented
with 10% fetal bovine serum in 5% CO2 atmosphere, as described
previously [80]. J774 macrophages resistant to ciprofloxacin
(referred to as CIP-R cells) were obtained as described earlier
[4]. In brief, wild-type cells were cultivated in the presence of
increasing concentrations of ciprofloxacin (from 0.1 mM to
0.2 mM) for about 50 passages (approx. 8 months), after which
cells were maintained in the presence of 0.2 mM ciprofloxacin.
MDCKII-MRP1 cells [81] were received from Prof. P. Borst (The
Netherlands Cancer Institute, Amsterdam, The Netherlands), and
grown in DMEM medium supplemented with 10% fetal bovine
serum in 5% CO2 atmosphere.
Metabolic Labeling with Stable Isotopes
Before performing the SILAC experiment, a time course of
incorporation of labeled amino acids was performed to establish
the minimum time required for complete labeling of proteins. Both
WT- and CIP-R macrophages were grown in the double labeled
[U-13C6] L-Lysine, [U-
13C6] L-Arginine SILAC medium (+6 Da
shift) in 20 cm2 dishes seeded at 16105cells/cm2 (RPMI-1640
SILACTM Protein Identification and Quantitation Media Kit,
Invitrogen). Whole cell lysates were prepared at various time
points in 10 mM Tris-HCl, pH 7.4 plus 0.1% SDS and random
peptides were analyzed by MS to evaluate incorporation of the
heavy amino acids. Two passages were sufficient for the WT-J774
cells to reach complete incorporation of the heavy isotopes. SILAC
labeling was thus performed with WT cells, while CIP-R cells were
grown in medium with light amino acids.
Preparation of Enriched Plasma Membrane Fractions
Cell monolayers (10 Petri dishes of 165 cm2, seeded at approx.
1.756105 cells/cm2) were rinsed with cold PBS then detached
with policeman and collected in the same buffer by centrifugation
at 2806g for 10 min at 4uC. Sets of 5 monolayers were pooled and
resuspended in 5 mL of 10 mM Tris-HCl, pH 7.4 plus protease-
inhibitor cocktail-EDTA free (one tablet/10 ml; F. Hoffmann-La
Roche Ltd Diagnostics Division, Basel, Switzerland). Cell suspen-
sions were transferred to a Dounce B homogenizer (glass/glass,
tight pestle) and stroked 25 times. The homogenates were
centrifuged at 6006g for 10 min at 4uC. The post-nuclear
supernatants were layered on the top of discontinuous sucrose
gradients designed to separate membranes from the other main
cell constituents [82]. Sucrose solutions were prepared in 10 mM
Tris-HCl, pH 7.4 plus 0.5 mM phenylmethanesulphonyl fluoride
(PMSF) and stored overnight at 4uC. Sucrose step gradients were
assembled on ice, layering cold solutions of sucrose using a syringe
with long needle in the following order: 1.5 ml of 1.10 density
solution, 1 ml of 1.13 density solution, 1 ml of 1.15 density
solution, 2 ml of 1.17 density solution and 2 ml of 1.19 density
solution. Gradients were ultracentrifuged in a Beckman SW40
rotor at 280.0006g for 2 h at 4uC. The resulting visible bands at
each interphase (Fig. 1A) constituted 5 different membrane
fractions (F1 to F5). The five fractions were collected on ice and
diluted to 6 ml with cold 0.1 M Na2CO3, pH 11 and centrifuged
in a Type 50 Ti rotor at 100,0006g for 30 min at 4uC. The
membrane pellets were then resuspended in 10 mM Tris-HCl,
Figure 6. Validation by Western blot of differentially expressed
proteins. Western blots of membrane proteins prepared from wild-
type (WT) and ciprofloxacin-resistant (CIP-R) J774 macrophages. Gels
were loaded with the indicated amounts of proteins. Top: Detection of
Dnajc3 with a rabbit anti-mouse Dnajc3 polyclonal antiserum (1:500)
and prohibitin with an anti-prohibitin polyclonal antibody (1:500)
followed by the appropriate anti-IgG HRP-labeled antibodies. Bottom:
Revelation of amyloid precursor protein App with a rabbit antiserum
(1:2000) and of prohibitin as loading control, followed by the
appropriate anti-IgG HRP-labeled antibodies (1:5000). For Tlr-7 detec-
tion, gels were loaded with the amounts of protein indicated and
revealed with anti-Tlr7 antibody (1:75), followed by the appropriate
anti-IgG HRP-labeled antibody (1:250).
doi:10.1371/journal.pone.0058285.g006
Figure 7. ER stress response evaluation. Immunoblot of Grp78 and
actin as loading control in whole cell lysates from cells growing in
standard conditions (line 1, WT cells in control medium; line 2, CIP-R
cells in medium added by 0.2 mM ciprofloxacin), or in WT cells exposed
for 24 h to 0.2 mM ciprofloxacin (line 3), or in cells exposed for 24 h to
0.5 mg/ml tunicamycin (TM; line 4, WT cells; line 5, CIP-R cells). The anti-
Grp78 is a rabbit antiserum used at 1:500 dilution. The hatched square
highlights the standard conditions of culture for each cell line.
doi:10.1371/journal.pone.0058285.g007
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pH 7.4 plus protease-inhibitor cocktail-EDTA free and aliquots
were removed for protein content determination using the
bicinchoninic acid protein assay (Pierce, Rockford, IL). Membrane
samples were then flash-frozen in an ethanol-dry ice bath and
stored at –80uC for downstream analysis.
Western Blot
After heating for 10 min at 70uC, membrane protein samples
were loaded on acrylamide gels (NuPAGE Bis-Tris 4–12% gels,
Invitrogen). After migration, separated proteins were transferred
onto nitrocellulose membranes and then blocked overnight at 4uC
in TBS-T (20 mM Tris-HCl, 500 mM NaCl pH 7.5 and 0.05%
Tween 20) with 5% milk. Blotted membranes were exposed to
appropriate primary antibodies, namely rabbit polyclonal anti-
TLR7 (IMG-581A; Imgenex, San Diego, CA), rat monoclonal
antibody anti-MRP1 (MRPr1, Alexis Biochemicals, Lausen,
Switzerland), and sc-28259 (Santa Cruz Biotechnology, Santa
Cruz, CA) to detect prohibitin, or to antisera against mouse
DnajC3 [83], against the amyloid precursor protein APP (A8717,
Sigma), or a rabbit antiserum against GRP78 (PA1-014A; Enzo
Life Sciences International, Inc., Plymouth Meeting, PA; kindly
provided by D. Tyteca, Institute de Duve and Universite´
catholique de Louvain, Brussels, Belgium), followed by appropri-
ate horseradish peroxidase-coupled secondary antibody (see figure
captions for dilutions). Blots were revealed by a chemilumines-
cence assay (SuperSignal West Pico, Pierce).
SDS-PAGE and In-Gel Digestion
Membrane fractions F1 and F2 were separately collected for
each cell line (Fig. 2A). To extract proteins from the membrane
fractions, samples were resuspended in the extraction/solubiliza-
tion buffer (7M urea, 2 M thiourea, 2% C7BzO and 5 mM
tributyl phosphine [TBP]). Matching fractions (F1wt+F1CIP and
F2wt+F2CIP) were mixed at concentration ratios of 1:1 (12C-light:
13C-heavy) and subjected to separation by SDS-PAGE as a single
sample. The mixed fractions are denominated pooled F1 and
pooled F2, respectively. After separation by SDS-PAGE, the
pooled F1 and F2 membrane fractions complete lanes were sliced
into small gel bands (Fig. 2B). Each band was in-gel digested as
previously described [84]. In short, gel bands were first destained
by two consecutive washes in 150 ml buffer containing 200 mM
ammonium bicarbonate in 50% (v/v) acetonitrile in water for
30 min at 30uC. After drying the gel pieces in a Speedvac
(Thermo Savant, Holbrook, NY), 10 ml trypsin solution (0.002 mg/
ml in a 50 mM ammonium bicarbonate buffer solution) was added
and allowed to be absorbed by the gel for 40 min on ice. Gel
bands were completely immersed by adding additional buffer
solution and incubated at 37uC. After overnight digestion, tryptic
peptides were extracted by 2 consecutive washes in 50 ml buffer
(60% (v/v) acetonitrile, 0.1% (v/v) formic acid in water). Pooled
peptide extractions were subsequently dried in a speedvac,
dissolved in 15 ml 2% (v/v) acetonitrile, 0.1% (v/v) formic acid
in water and stored at -20uC for further analysis.
Liquid Chromatography Electrospray Ionization Fourier
Transform Tandem Mass Spectrometry (LC-ESI-FT-MS/
MS)
Tryptic peptides from each gel band were individually analyzed
via a fully automated LC-MS/MS setup. Peptides were first
separated on an Agilent 1200 chromatographic system (Agilent,
Santa Clara, CA) and on-line measured on a LTQ-FT Ultra mass
spectrometer (Thermo Fisher Scientific, Waltham, MA). Peptides
in 5 ml solution were initially concentrated and desalted on a
Zorbax 300SB-C18 trapping column, 5 mm60.3 mm, at a 4 ml/
min flow rate using a 2% (v/v) acetonitrile, 0.1% formic acid in
water buffer. After valve switching, eluted peptides were separated
on a Zorbax 300SB-C18 analytical column, 150 mm675 mm
(Agilent), by a 50 min linear gradient ranging from 2% (v/v) to
80% (v/v) acetonitrile, 0.1% formic acid in water at a 250 nl/min
flow rate. Eluting peptides were analyzed on-line in the mass
spectrometer via nano-ESI. Protein digests from fraction F2 were
measured using the LTQ-FT Ultra nano-ESI source and applying
a 1.1 kV voltage on PicoTip emitters (New Objective, Woburn,
MA). For fraction F1 digests, LC-effluent was directly coupled to a
Triversa NanoMate ESI source (Advion, Ithaca, NY), working in
nano-LC mode and equipped with D-chips whereon a 1.55 kV
voltage was supplied. The LTQ-FT Ultra mass spectrometer was
tuned and calibrated with caffeine, MRFA (met-arg-phe-ala
peptide) and UltraMark before measurement. The Fourier-
transform ion cyclotron resonance (FT-ICR) mass analyzer
acquired MS scans at 100,000 resolution during the LC
separation. The 3 most intense precursor peptides for each MS
scan were automatically selected and fragmented by the LTQ ion
trap mass analyzer, and after 2 occurrences, precursor masses were
excluded for 90 sec.
Data Processing and Analysis
Raw LC-MS/MS data were analyzed with the Sequest
database-searching algorithm [85] implemented in the Bioworks
v3.3.1 software (Thermo Fisher Scientific). MS/MS spectra were
searched against the mouse uniprot protein database concatenated
with a shuffled decoy database generated by the Decoy Database
Builder software tool [86] Propionamide on cysteines (+71.037114)
and SILAC labels in arginine and lysine (+6.020129) were allowed
as variable modifications. Mass tolerances were set to 10 ppm and
0.5 amu for peptide mass and fragment mass respectively. Two
miscleavages and only b- and y-ions were considered. Raw LC-
MS/MS data and Sequest result files were loaded into the TPP
software v3.4 (Seattle Proteome Center [87]). Peptide identifica-
tions were validated with PeptideProphet filtering out peptide hits
with probabilities below 0.70. Retained peptide identifications
were subsequently quantified via the ASAPRatio tool using a fixed
scan range for Light and Heavy labeled peptides and a 6.02013 Da
label mass for both arginine and lysine. Mass tolerance was set to
0.01 Da. For each individual LC-run, peptide identifications and
quantifications were grouped via the ProteinProphet tool and
afterwards exported as excel files for further processing. All
peptide and protein L/H ratios were manually controlled and if
necessary adjusted. Manually validated protein ratios for each
individual LC-run were grouped for redundant protein identifi-
cations via in-house written VBA (Visual Basic Scripting Edition)-
scripts. Only proteins with a probability of 0.95 or higher were
retained in the script. Final protein abundance ratios were
subsequently calculated by averaging the logarithm base 2 protein
ratios of an individual protein present in multiple gel bands. The
final proteins ratios were normalized towards the median and their
p-values calculated based on Z-statistics as previously described
[88]. Unambiguously identified and quantified proteins from
pooled fractions F1 and F2 were submitted to the online available
DAVID Bioinformatics tool [89] and analyzed via their respec-
tively GO terms for cellular localization and biological process. All
MS data are available on the EBI’s PRIDE mass spectral
depository (accession numbers 17116–17117). All samples were
run in duplicate, as previously done by other groups using the
SILAC technique [8,90]. A main advantage of this approach
resides indeed in the fact that it allows a relative quantification of
proteins in a single sample obtained by mixing material collected
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from two different experimental conditions (in our case, WT and
CIP-R cells), reducing the need of replicated samples. Moreover,
quantitation is based on ratio’s obtained from different peptides
per protein for which we used stringent conditions to accept a ratio
as significant.
Supporting Information
Figure S1 Amino acid sequence of the cathepsin B
precursor (P10605). Arrows indicate the cleavage sites for the
proteolytically activation of the protein precursor : Signal peptide
(1–17), Propeptide (18–79), Cathepsin B (80–333), Light chain (80–
126), Heavy chain (129–333) and Propeptide (334–339). Under-
lined sequences represent tryptic peptides identified specifically in
gel bands 53–58 as shown in figure 2. Sequences in bold represent
tryptic peptides identified specifically in gel bands 64 and 65. Not all
tryptic peptides depicted here are identified in all mentioned gel
bands, although their respectively precursors are present in the LC-
MS data; except for three precursors specific for the upper gel bands
which were absent in the lower bands (sequences in italic),
demonstrating the appearance of the intact precursor in the upper
gel region and the processed cathepsin B in the lower region.
(TIF)
Table S1 List of the 900 proteins identified (with at least 3
unique peptides using a 0.95 significancy threshold [P-value]). (651
proteins in fraction F1, 735 proteins in fraction F2).
(XLS)
Table S2 List of proteins represented by only 1 or 2 peptides
using a 0.95 significancy threshold [P-value]). (386 proteins in
fraction F1, 381 proteins in fraction F2).
(XLS)
Table S3 Distribution of cathepsin B (P10605) within the SDS-
gel lane of pooled sample F1 and the respectively protein
abundance ratios as calculated by ASAPRatio for each individual
gel band.
(DOC)
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Table S3 : Distribution of cathepsin B (P10605) within the SDS-gel lane of pooled sample F1 and 
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